Dose Response Study of Levalbuterol in the Prevention of Exercise Induced Bronchoconstriction Compared to Racemic Albuterol

NCT00685425 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma
Bronchoconstriction

Interventions

DRUG: Levalbuterol HFA MDI
DRUG: Racemic Albuterol

Sponsor

Sumitomo Pharma America, Inc.